The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.
The massive crash came after the US Food and Drug Administration (FDA) website showed the end of the shortage of Novo Nordisk ...
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular ...